Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX
Putilina MV, Mutovina ZY, Kurushina OV, Khalilova DM, Saverskaya EN, Stepanova SB, Khoreva MA, Starikov AS · 2022 · Zh Nevrol Psikhiatr Im S S Korsakova 122(1):84-90. PMID 35175707
What does this source report?
Observational follow-up recorded fatigue, cognitive and other post-COVID complaints and changes during treatment.
- Population and setting
- CORTEX post-COVID program; 979 patients
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- No randomized untreated control is described.
- Symptom recovery and confounding remain plausible explanations; questionnaires are not wearable sleep stages.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Putilina MV, Mutovina ZY, Kurushina OV, Khalilova DM, Saverskaya EN, Stepanova SB, Khoreva MA, Starikov AS. Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX Zh Nevrol Psikhiatr Im S S Korsakova 122(1):84-90. PMID 35175707 2022.
Molekul research summary: https://molekul.io/research/bio-35175707. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry